Get in touch with one of our Xperts.
Introduction As pharmaceutical drugs become physically larger, from small molecules to biologics to gene and cell therapies, so their molecular complexity increases. Small molecule drugs can be defined at the atomic level: it is known where each atom should be and how it should be connected to others. Methods are therefore developed to measure and continue reading…
3D-PharmXchange is proud to be a partner in the BRECISE project (Biomarker Research and Evaluation for Clinical Implementation and Supporting Systems Enhancement), a five-year initiative co-funded by the Innovative Health Initiative (IHI) under Horizon Europe. The project brings together more than 30 public and private organizations across Europe with the shared goal of accelerating the continue reading…
3D-PharmXchange is proud to announce its collaboration with Antleron in the Living Factory 4.0 project. Antleron is a Leuven-based R&D company that develops custom bioprocess solutions for cell & gene therapy applications, with a focus on personalized and digital manufacturing. The Living Factory 4.0, supported by the CrossRoads program, aims to revolutionize the development and production of continue reading…
© 3D-PharmXchange 2026